TiGenix obtains production licence for expanded adipose-derived stem cells in Spain

Belgian biopharmaceutical company TiGenix has received a licence for the commercial production of expanded adipose-derived stem cells (eASCs) at its extended manufacturing facility in Madrid, Spain.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news